Nothing Special   »   [go: up one dir, main page]

TR200100055T2 - Paroksetin tuzları - Google Patents

Paroksetin tuzları

Info

Publication number
TR200100055T2
TR200100055T2 TR2001/00055T TR200100055T TR200100055T2 TR 200100055 T2 TR200100055 T2 TR 200100055T2 TR 2001/00055 T TR2001/00055 T TR 2001/00055T TR 200100055 T TR200100055 T TR 200100055T TR 200100055 T2 TR200100055 T2 TR 200100055T2
Authority
TR
Turkey
Prior art keywords
paroxetine
salts
compounds
therapy
pharmaceutical compositions
Prior art date
Application number
TR2001/00055T
Other languages
English (en)
Turkish (tr)
Inventor
Victor Jacewicz Witold
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200100055T2 publication Critical patent/TR200100055T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
TR2001/00055T 1998-07-02 1999-06-30 Paroksetin tuzları TR200100055T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds

Publications (1)

Publication Number Publication Date
TR200100055T2 true TR200100055T2 (tr) 2001-07-23

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00055T TR200100055T2 (tr) 1998-07-02 1999-06-30 Paroksetin tuzları

Country Status (21)

Country Link
EP (1) EP1091958A1 (zh)
JP (1) JP2002519421A (zh)
KR (1) KR20010053337A (zh)
CN (1) CN1314906A (zh)
AP (1) AP2000002017A0 (zh)
AU (2) AU4903999A (zh)
BG (1) BG105204A (zh)
BR (1) BR9911679A (zh)
CA (1) CA2336470A1 (zh)
CZ (1) CZ20004923A3 (zh)
EA (1) EA200100098A1 (zh)
GB (1) GB9814316D0 (zh)
HU (1) HUP0103712A3 (zh)
ID (1) ID27766A (zh)
IL (1) IL140385A0 (zh)
NO (1) NO20006547L (zh)
PL (1) PL345365A1 (zh)
SK (1) SK20242000A3 (zh)
TR (1) TR200100055T2 (zh)
WO (1) WO2000001692A1 (zh)
ZA (2) ZA992899B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1622630T3 (da) 2003-05-07 2012-12-17 Osteologix As P009368epdk1
JP4354984B2 (ja) 2003-05-07 2009-10-28 オステオロジックス エイ／エス 水溶性ストロンチウム塩を用いる軟骨／骨症状の治療
EP1732575B1 (en) 2004-02-26 2010-12-29 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) * 2006-07-27 2020-03-02 Wang Nai Fang Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN109212055B (zh) * 2018-08-19 2021-05-07 丁立平 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) * 2018-11-27 2020-10-02 北京市化工职业病防治院 尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 一种高稳定性Halo-tag探针及其合成和生物应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
DE29724281U1 (de) * 1997-06-10 2000-08-10 Synthon Bv 4-Phenylpiperidin-Verbindungen
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염

Also Published As

Publication number Publication date
HUP0103712A2 (hu) 2002-05-29
EA200100098A1 (ru) 2001-08-27
AP2000002017A0 (en) 2000-12-31
SK20242000A3 (sk) 2001-07-10
CZ20004923A3 (cs) 2001-08-15
NO20006547L (no) 2001-02-12
ZA992899B (en) 2000-03-29
GB9814316D0 (en) 1998-09-02
BR9911679A (pt) 2002-01-29
EP1091958A1 (en) 2001-04-18
PL345365A1 (en) 2001-12-17
BG105204A (en) 2001-11-30
CN1314906A (zh) 2001-09-26
ID27766A (id) 2001-04-26
IL140385A0 (en) 2002-02-10
ZA200100020B (en) 2002-03-25
CA2336470A1 (en) 2000-01-13
JP2002519421A (ja) 2002-07-02
AU2002100370A4 (en) 2002-06-06
AU4903999A (en) 2000-01-24
NO20006547D0 (no) 2000-12-21
HUP0103712A3 (en) 2002-09-30
KR20010053337A (ko) 2001-06-25
WO2000001692A1 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
ES2158778A1 (es) Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
BR0016543A (pt) Novos derivados de piperidina e piperazina
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
DK0891331T3 (da) N-(2-Oxoacetyl- eller sulfonyl)pyrrolidin/piperidin-2-carboxylsyrederivater med forbedret multi-lægemiddelresistensaktivitet
NO20013538L (no) Piperidin, tetrahydropyridin og piperazinderivater, deres fremstilling og anvendelse
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
EE03523B1 (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
EE04399B1 (et) Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis
TR200101397T2 (tr) Piperidin CCR-3 reseptörü antagonistleri
SE9900961D0 (sv) Novel compounds
EE04054B1 (et) Tetrasoolderivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldav ravim
NO20021859L (no) Nye oligosakkarider, deres fremstilling samt farmasöytiske preparater inneholdende oligosakkaridene
DE69531098D1 (de) Piperidine und pyrrolidine
EE200100104A (et) 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
NO20024076L (no) Sammensetning omfattende camptotecin og et pyrimidinderivat for behandling av cancer
TR200100055T2 (tr) Paroksetin tuzları
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE9802209D0 (sv) Novel compounds
ATE384049T1 (de) Therapeutische heterocyclen als bradykinin b2 rezeptor antagonisten
JO2199B1 (en) Replaced pyrrols